Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Stealth BioTherapeutics Inc.

Clinical trials sponsored by Stealth BioTherapeutics Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can a daily injection save your sight? new trial for dry AMD Results expected Aug 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New drug aims to help mitochondrial disease patients walk farther

Disease control Completed

This Phase 3 trial tested a daily injection called elamipretide in 102 adults with primary mitochondrial myopathy, a genetic condition that causes muscle weakness and fatigue. Participants received either the drug or a placebo for 48 weeks. The main goal was to see if the drug co…

Phase 3 • Sponsor: Stealth BioTherapeutics Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:55 UTC